- Q1 2024 Intra-Cellular Therapies Inc Earnings Call TranscriptMay 07, 2024MXN1251.41Earnings
- Q4 2023 Intra-Cellular Therapies Inc Earnings Call TranscriptFeb 22, 2024MXN1020.67Earnings
- Intra-Cellular Therapies Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Intra-Cellular Therapies Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Intra-Cellular Therapies Inc Earnings Call TranscriptNov 02, 2023MXN1135.67Earnings
- Intra-Cellular Therapies Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Intra-Cellular Therapies Inc at Canaccord Genuity Growth Conference TranscriptAug 09, 2023
- Q2 2023 Intra-Cellular Therapies Inc Earnings Call TranscriptAug 03, 2023MXN1135.67Earnings
- Intra-Cellular Therapies Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Intra-Cellular Therapies Inc at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2023
- Intra-Cellular Therapies Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Intra-Cellular Therapies Inc Earnings Call TranscriptMay 04, 2023MXN1135.67Earnings
- Intra-Cellular Therapies Inc LUMATEPERONE Study 403 Topline Results TranscriptMar 28, 2023
- Q4 2022 Intra-Cellular Therapies Inc Earnings Call TranscriptMar 01, 2023MXN987.74Earnings
- Intra-Cellular Therapies Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Q3 2022 Intra-Cellular Therapies Inc Earnings Call TranscriptNov 03, 2022Earnings
- Q2 2022 Intra-Cellular Therapies Inc Earnings Call TranscriptAug 09, 2022Earnings
- Q1 2022 Intra-Cellular Therapies Inc Earnings Call TranscriptMay 10, 2022Earnings
- Q4 2021 Intra-Cellular Therapies Inc Earnings Call TranscriptMar 01, 2022Earnings
- Intra-Cellular Therapies Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Q3 2021 Intra-Cellular Therapies Inc Earnings Call TranscriptNov 09, 2021Earnings
- Intra-Cellular Therapies Inc to Feature Highlights of Several of its Development Programs TranscriptOct 20, 2021
- Q2 2021 Intra-Cellular Therapies Inc Earnings Call TranscriptAug 09, 2021Earnings
- Intra-Cellular Therapies Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Intra-Cellular Therapies Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Q1 2021 Intra-Cellular Therapies Inc Earnings Call TranscriptMay 10, 2021Earnings
- Intra-Cellular Therapies Inc Investor Webcast on Lumateperone Programs TranscriptMay 04, 2021
- Q4 2020 Intra-Cellular Therapies Inc Earnings Call TranscriptFeb 25, 2021Earnings
- Intra-Cellular Therapies Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Q3 2020 Intra-Cellular Therapies Inc Earnings Call TranscriptNov 09, 2020Earnings
- Intra-Cellular Therapies Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Intra-Cellular Therapies Inc to Discuss Positive Topline Results from Study 402 - Conference Call TranscriptSep 09, 2020
- Q2 2020 Intra-Cellular Therapies Inc Earnings Call TranscriptAug 10, 2020Earnings
- Q1 2020 Intra-Cellular Therapies Inc Earnings Call TranscriptMay 07, 2020Earnings
- Q4 2019 Intra-Cellular Therapies Inc Earnings Call TranscriptMar 02, 2020Earnings
- Intra-Cellular Therapies Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Intra-Cellular Therapies Inc Earnings Call TranscriptNov 05, 2019Earnings
- Intra-Cellular Therapies, Inc. - Special Call TranscriptAug 05, 2019
- Intra-Cellular Therapies Inc to Discuss the Top-line Results of Studies 401 and 404 Call TranscriptJul 08, 2019
- Q1 2019 Intra-Cellular Therapies Inc Earnings Call TranscriptMay 08, 2019Earnings
Intra-Cellular Therapies Inc at Goldman Sachs Healthcare Conference Transcript
All right. Well, we're getting started. Great to see you. Thanks, everyone, for joining us today, and thanks for the team from Intra-Cellular for joining us as well. Maybe just we could start with a brief overview. If you could -- brief overview on where the company stands today and what you see as key value drivers over the next 12 to 24 months?
Right, so thanks. It's great to be here. Although it's nice and warm in here, so that's really terrific as opposed to out there where it's pretty cold. So let me just give you an overview on the company. We started the company in 2002. And what's great today, first of all, is our first product, CAPLYTA, which first got approval in 2019 for the treatment of schizophrenia in adults. Fast forward to December 2021 and received a label expansion for the treatment of bipolar depression.
And really, in the past year, since that launch for bipolar depression, we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)